Ledger.Open graph →

SEC Form D · filed September 30, 2016

Roka BioScience, Inc

Offering

$22.5M

Sold

$22.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

WARREN, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Lars Boesgaard · Warren, NJExec Nicholas G. Valeriani · Warren, NJDirector Jim G. Barret, Phd · Warren, NJDirector Michael P. Doyle · Mason, OHDirector Fred G. Cohen · Warren, NJDirector Jonathan G. Silverstein · Warren, NJDirector Paul G. Thomas · Warren, NJExec · Director Colleen Taylor · CHARLOTTE, NCExec · Director Brad Feld · Charlotte, NCDirector Joel Wilhite · CHARLOTTE, NCDirector Jim Hausman · CHARLOTTE, NCDirector Nicolas Westphal · CHARLOTTE, NCDirector David G. Mcgirr · Warren, NJDirector Deepak Sindwani · Boston, MADirector Vaibhav Nalwaya · Boston, MADirector Tony M. Abena · Seattle, WADirector Perry M. Fischer · Seattle, WADirector Louis G. Fasulo · Seattle, WAExec · Director Lars Boesgaard · Warren, NJExec David G. Mcgirr · Warren, NJDirector Nicholas G. Valeriani · Warren, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗